EMEA-002440-PIP01-18-M03
Key facts
Invented name |
Xofluza
|
Active substance |
Baloxavir marboxil
|
Therapeutic area |
Infectious diseases
|
Decision number |
P/0383/2022
|
PIP number |
EMEA-002440-PIP01-18-M03
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Roche Registration GmbH
Tel. +41 6169 79411 |
Decision type |
PM: decision on the application for modification of an agreed PIP
|